Single-sample expression-based chemo-sensitivity score improves survival associations independently from genomic mutations for ovarian cancer Patients
Platinum-based chemotherapies are first-line treatments for ovarian cancer (OC) patients. Although chemotherapy has a high initial response rate, some patients exhibit inherent chemo-resistance. With advancements of molecular and genomic profiling, it is of high interest to identify molecular and ge...
| Main Authors: | , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
American Medical Informatics Association
2016
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5001782/ |